Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan. 2004

Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
First Department of Medicine, Chiba University School of Medicine, Japan. kandat-cib@umin.ac.jp

OBJECTIVE Hepatitis C virus (HCV) is the most common cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. It is controversial whether HCV causes fulminant hepatitis. METHODS To determine the clinical features and etiology of acute hepatitis and fulminant hepatitis in Japan, an endemic area of hepatitis C, between 1986 and 2001 inclusively, a retrospective study of consecutively referred patients was performed. Two hundred and sixty-three patients admitted to a liver clinic after diagnosis of acute hepatitis or fulminant hepatitis, were evaluated. RESULTS We found 181 cases of acute hepatitis and 82 cases of fulminant hepatitis/late onset hepatic failure. No cases of fulminant hepatitis were positive for HCV RNA. Only three cases had positive anti-HCV antibody, and they were thought to indicate past HCV infection. The main cause of infection in these three patients was hepatitis A virus in one,hepatitis B virus in one, and drugs in the remaining one. HCV did not seem to be the major cause. The three cases died without receiving liver transplantation. CONCLUSIONS It was revealed that fulminant hepatitis C rarely occurs in Japan, as well as in the USA and European countries. Investigators should search for other causes in fulminant cases presenting an HCV marker.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological
D017093 Liver Failure Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed) Hepatic Failure

Related Publications

Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
January 1995, The American journal of gastroenterology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
March 1996, Lancet (London, England),
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
June 1994, Lancet (London, England),
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
July 1991, Gastroenterologia Japonica,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
January 1998, Nihon Jinzo Gakkai shi,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
September 2011, Acta paediatrica (Oslo, Norway : 1992),
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
February 2019, Anaesthesia, critical care & pain medicine,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
March 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
July 1991, Gastroenterologia Japonica,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Hiromitsu Saisho
February 2021, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Copied contents to your clipboard!